-
Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study.
Department of Preventive Medicine and USC/Norris Comprehensive Cancer Center and Hospital, University of Southern California Keck School of Medicine, Los Angeles, California 90089-9176, USA.
PMID: 11927504 [PubMed - indexed for MEDLINE]
-
Cited by 2 PubMed Central articles
-
Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.
Beesley J, Jordan SJ, Spurdle AB, Song H, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, McGuire V, Whittemore AS, et al.
Cancer Epidemiol Biomarkers Prev. 2007 Dec; 16(12):2557-65.
[Cancer Epidemiol Biomarkers Prev. 2007]
-
SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.
Neslund-Dudas C, Bock CH, Monaghan K, Nock NL, Yang JJ, Rundle A, Tang D, Rybicki BA.
Prostate. 2007 Nov 1; 67(15):1654-63.
[Prostate. 2007]